PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
ANNAPOLIS, Md., July 30 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in
Jul 30, 2010
Latest in Home
Why Experts Think U.S. Trade Policy Causes More Damage Than Good
October 12, 2026


















